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Abstract
Objective To report outcomes of nonsurgical and surgical management of Menière's disease at Beijing Tiantan Hospital．
Methods Patients with Menière's disease were categorized into groups based on hearing and quality of life. Individualized
management was provided, including life style modification, drug therapies, endolymphatic sac decompression and labyrin-
thectomy. Treatment outcomes were evaluated during up to 24 months follow up．Results Eighty seven patients under-
went life style modification and drug therapies. The vertigo control rate of Grade A and B was 76.9% and 83.8% respec-
tively. Six patients received surgical management, including endolymphatic sac decompression (n = 5) and labyrinthecto-
my (n = 1)． For these patients, the vertigo control rate of Grade A and B was 80% and 100%, respectively. Conclu-
Isions Management of Menière's disease depends on several factors, i.e. severities of vertigo and hearing loss, quality of
life, surgical contraindications and patient subjective desire. The treatment is drug therapies for the majority of patients, as
well as life style modification. Surgical indications are rare and the least invasive procedures should be considered first.
The results of surgery are generally satisfying.
Introduction
Meniere’s disease (MD) or endolymphatic hydrops is
an idiopathic inner ear disorder characterized by attacks
of vertigo, fluctuating hearing loss, tinnitus, and aural
fullness[1] . Knapp in 1871 thought that Meniere’s dis-
ease was caused by elevated endolymphatic pressure.
Meniere’s disease is a clinical diagnosis. There is no spe-
cific diagnostic test for Meniere’s disease[2]. The diagnos-
tic evaluation of Meniere’s disease primarily includes
audiometry and a fluorescent treponemal antibody ab-
sorption to rule out syphilis. Electrophysiologic studies
that evaluate vertigo and nystagmus with caloric, rota-
tional, and galvanic testing are used to differentiate and
categorize peripheral and central vestibular disorders.
Other serologic studies and imaging are obtained as need-
ed. The role of allergy testing continues to be debated.
The treatment is medical in the majority and operation-
al in the minority of patients, although there is no inter-
national consensus on the management of different stag-
es of Menière's disease[3]. This study reports treatment
outcomes in 93 patients with Meniere’s disease treated
from June 2008 to May 2011 at Beijing Tiantan Hospital.
Materials and Methods
Ninety three patients with Menière's disease treated
from June 2008 to May 2008 in the Department of Oto-
laryngology Head and Neck Surgery, Beijing Tiantan
Hospital, Capital Medical University, were included in
this study (40 males with an average age of 33.1 ± 12.2
years, and 53 females with an average age of 34.5±15.78
years). Of these patients, 5 presented with bilateral symp-
toms. The diagnosis was made based upon the 1995
AAO-HNS criteria by the“Committee on Hearing and
Equilibrium Guidelines for the Diagnosis and Evaluation
of Therapy in Menière's Disease”, as well as audiological
and vestibular function tests results. According to the
AAO-HNS guidelines, vertigo was classified as Grades [1-6]
and hearing level as Stages [1-4], i.e. Stage 1: PTA (pure
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tone average) < 25 dB HL; Stage 2: PTA 26-40 dB HL;
Stage 3: PTA 41-70 dB HL; Stage 4: PTA > 70 dB HL.
Vertigo in the 93 patients was classified as Grade 1 in
4 patients, Grade 2 in 9 patients, Grade 3 in 37 patients,
Grade 4 in 18 patients, Grade 5 in 10 patients and Grade
6 in 1 patient. Hearing levels were determined to be
Stage 1 in 11 patients, Stage 2 in 38 patients, Stage 3 in
39 patients, and Stage 4 in 5 patients.
Management included life style modification in 13 cas-
es with Grade 1-2 vertigo, drug therapies in 74 cases
with Grade 3-5 vertigo, and surgery in 6 cases with
Grade 5-6 vertigo.
Life style modification
Life style modification in 13 cases with grade l-2 vertigo
included
1) avoidance of work-related stress or to overwok ,
staying up late
2) avoidance ofto excessive tensionstress and manage-
ment of，depression, , alleviation of anxiety or and fear
mentality
3) restrictions on consumption of nicotine, and alcohol
4) restrictions on caffeineated beverage and food，tea，
chocolate
5) restriction on salt intake
Pharmacological treatment
Drugs: hydrochlorothiazide (25 mg, qd - tid）+ Potassi-
um chloride sustained-release (1.0 g, qd-tid）+ betahis-
tine (12 mg, tid).
Duration of treatment:1-3 months as determined by re-
sponse to treatment.
Surgery
Surgical treatment included endolymphatic sac decom-
pression (ESD) in 5 patients with grade 5 vertigo and lab-
yrinthectomy in 1 patient with grade 6 vertigo, after unsat-
isfying pharmacological treatment of at least half a year.
The 6 cases included 3 males (average age = 41.1±12.8
years) and 3 females (average age = 53.8±14.7 years), all
with unilateral MD. Severity of vertigo and hearing level
were evaluated after operation in these patients.
Treatment outcomes evaluation
Vertigo outcomes were rated as Grades A-E according
to“The diagnosis and evaluation of therapy in Menière's
disease”in the Chinese Journal of Otolaryngology Head
and Neck Surgery”[4], where Grade A (0) = complete ver-
tigo control, Grade B (1-40) = near complete vertigo con-
trol, Grade C (4l-80) = partial vertigo control, Grade D
(8l-120) = vertigo not controlled, and Grade E (>120) =
vertigo aggravated.
Results
Nonsurgical treatment outcomes
In the 13 patients undergoing life style modification, 7
achieved Grade A and 3 achieved Grade B vertigo con-
trol. Life style modification in the other 3 cases was not
satisfying and followed by pharmacological treatment.
The overall rate of Grade A or B vertigo control was
76.9% in this group of patients.
In the 74 cases receiving pharmacological treatment,
vertigo control was Grade A in 25 cases, Grade B in 37
cases and Grade C in 12 cases. The combined Grade A
or B vertigo control rate was 83.8% in this group.
Surgical treatment outcomes
In the 5 cases receiving ESD (Figure1), vertigo con-
trol was Grade A in 2 cases, Grade B in 2 cases and
Grade C in 1 case The PTA before operation was 42.3±
23.2 dB HL and 47.2 ± 14.3 dB HL after operation. Im-
provement was reported in 2 of the 3 cases with tinnitus
and in 2 of the 4 cases with fullness. The combined
Grade A or B vertigo control rate was 80% in this group.
In the patient who underwent labyrinthectomy (Figure2),
the PTA was 83.9 dB HL before operation but indicated
total hearing loss after operation, although with total
(Grade A) vertigo control. There was no surgical compli-
cation in all these 6 patients.
Discussion
Menière's disease is defined by the association of 4
symptoms: vertigo attacks, fluctuating hearing loss, tinni-
Figure 1. Left, view of surgical field during endolymphatic sac de-
compression; right, CT scan after endolymphatic sac surgery. ES =
endolymphatic sac
Figure 2. left. CT scan before labyrinthectomy; right, CT scan af-
ter labyrinthectomy
107
2014 Vol.9 No.2
tus and an auricular plenitude sensation. The pathophysi-
ology is commonly explained by a distension of membra-
nous labyrinth by the endolymph, equally called endo-
lymphatic hydrops. Recent studies also tend to relate
the disease to immune mechanisms[3].
A large variety of medical and surgical treatments
have been introduced for Menière's disease. A postal sur-
vey amongst consultant otolaryngologists was carried
out by Smith WK[5]. It revealed that 52 per cent were ac-
tively involved in the treatment of patients with
Ménières disease using a wide range of medical and sur-
gical therapies that have little or no evidence base. The
survey found that 94 per cent of surgeons prescribe beta-
histine, 63 per cent diuretics and 71 per cent advise salt
restriction to their patients, while 52 per cent of surgeons
continue to recommend saccus decompression and 50
per cent are still inserting a grommet. However, two
thirds of respondents now advocate the use of gentami-
cin therapy despite it only being introduced to this coun-
try just over 10 years ago. Surgical indications are rare
and the least invasive procedures are used first. The
choice of the procedure should take into consideration
the need to preserve the auditory function of the patient[3].
Nonsurgical therapy in Menière's disease
Life stylemodificationas treatment forMenière's dis-
ease
Life style modification is very important to MD pa-
tients, especially to those whose life style involves
high salt diet, strong tea, overworking and emotional fluc-
tuations. According to our experience, life style modifica-
tion such as avoidance of overworking, excessive stress，
depression, caffeinated beverage, excessive consumption
of tea, chocolate, nicotine, alcohol and salt may yield con-
dition improvement especially in patients with mild MD.
In our study, the rate of grade A or B vertigo control was
76.9% in the 13 patients with Grade 1-2 vertigo.
Pharmacological management of Meniere's disease
The treatment of acute Menière's disease is basically
symptomatic control. Vestibular suppressant, anticholin-
ergic, anti-emetic drugs have a well-established record in
controlling acute attacks of vertigo. Sometimes, the ad-
ministration of benzodiazepines may help to alleviate
anxiety. In the post-crisis phase, the use of diuretics, his-
taminergic agents is popular3. Corticosteroids are used
in bilateral forms of Menière's disease, particularly if an
autoimmune basis is suspected3.
The use of diuretics
The primary management of Meniere’s disease in-
volves a low-sodium diet (1,500 mg/d) and diuretics (hy-
drochlorothiazide)6. Deelen and Huizing, in a hydrochlo-
rothiazide, double-masked, placebo-controlled, cross-
over study, showed that diuretics seem to improve the
vestibular complaints but have no effect on hearing or tin-
nitus[7]. But there is insufficient solid evidence supporting
the effect of diuretics on vertigo, hearing loss, tinnitus or
aural fullness in clearly defined Ménière's disease[8]. Ac-
cording to our experience, combined application of hy-
drochlorothiazide + potassium chloride sustained-re-
lease + betahistine is very effective in MD patients. The
course of treatment may vary according to treatment re-
sponse. An important point is monitoring blood pressure
to prevent hypotension because of blood pressure fall
from hydrochlorothiazide. In the 74 cases receiving phar-
macological treatment, vertigo severity was Grade A in
25, Grade B in 37 and Grade C in 12 cases. The com-
bined Grade A or B vertigo control rate was 83.8%.
Surgical therapy in Menière's disease
The majority of patients are controlled with conserva-
tive management. Patients who are refractory to medical
therapy may undergo intratympanic gentamicin therapy,
endolymphatic sac surgery or vestibular nerve section.
Patients without serviceable hearing may undergo intra-
tympanic gentamicin therapy or transmastoid labyrin-
thectomy[9]. The choice of surgical procedure depends on
the degree of serviceable hearing, severity of vertigo
spells and condition of the contralateral ear[10].
Endolymphatic sac decompression provides a nonde-
structive option for patients who fail medical or amino-
glycoside therapy and have good hearing. Kato[11] thinks
that the quality of life improvs in 87% patients receiving
ESD. Convert[12] thinks that ESD can also improve tinni-
tus. Kitahara et al think [13,14] that ESD, with its advantag-
es of easy operation, hearing preservation and excellent
vertigo control, should be the first choice of surgical
treatment in MD. But its success rates greatly vary in the
literature, so the benefit of ES is not universally accept-
ed. The role of endolymphatic surgery is currently in de-
cline with the renewed interest in intratympanic amino-
glycoside therapy[9]. Transmastoid labyrinthectomy with
removal of the bony semicircular canals, vestibule and
the membranous neuroepithelium provides control of
vertigo in nearly all patients with unilateral Meniere’s
disease and poor hearing. The complete loss of unilateral
vestibular function from labyrinthectomy leads to un-
steadiness in up to 30% of patients[15]. However, patients
undergoing translabyrinthine vestibular nerve section are
more likely to show improvement in imbalance and func-
tional disability[16]. There were 6 patients undergoing sur-
gical management in our series: endolymphatic sac de-
compression (Figure1) in 5 patients and labyrinthectomy
(Figure2) in 1 patient with combined Grade A or B verti-
go control rate greater than 80% . In this study, only a
few patients received surgical treatments, probably out
of the concern over risks of operational complications.
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In the future, we expect to accumulate more experiences
as we carry out more surgical treatments in MD patients.
Other surgical procedures in MD therapies include ves-
tibular nerve sectioning and intratympanic gentamicin in-
jection. Vestibular nerve sectioning provides a definitive
treatment of unilateral Meniere’s disease in patients with
serviceable hearing. Ninety-five percent of patients
achieve vertigo control, and hearing is preserved in over
95% of patients[2]. Intratympanic gentamicin injection en-
ables effective vertigo control in most patients, and repre-
sents a good alternative to more aggressive techniques
for the treatment of Ménière's disease which does not re-
spond to medical treatment[17]. The incidence of hearing
loss is significantly higher after gentamicin injection,
compared to vestibular neurectomy[18]. Recent studies
with weekly or monthly injections have shown nearly
90% vertigo control with 7 to 17% < 30 dB hearing loss
and less than 1% ≥ 30 dB hearing loss[19,20,21]. In the next
study, we will study the effectiveness of vestibular nerve
sectioning and Intratympanic gentamicin injection.
Conclusions
The management of Menière's disease depends on sev-
eral factors: severities of vertigo and hearing loss, level
of quality of life, surgical contraindications and patient
subjective desire. The treatment is non-surgical in the
majority of patients, including life style modification.
Surgical indications are rare and the least invasive proce-
dures are used first, usually with satisfying results.
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